香港药剂业及毒药管理局就采用 PIC/S GDP 指南公开征求意见
Implementation of GDP for Pharmaceutical Products in Hong Kong
香港药剂业及毒药管理局就药品实施 GDP 公开征求意见,拟采用 PIC/S 药品优良运销规范指南。卫生署药物办公室网站公布了 GDP 指南、业界指引及修订后的批发商牌照持有人实务守则三份草案文件。GDP 拟通过额外申请要求和或牌照条件引入,计划 2026 年第三季度先从新申请人开始,2028 年第三季度扩展至相关现有持牌人,征求意见期为 2026 年 4 月 1 日至 5 月 31 日。
材料列出香港拟采用 PIC/S GDP 指南的三份草案文件及分阶段实施安排,便于读者核对适用范围与时间节点。
The Pharmacy and Poisons Board of Hong Kong has launched a public consultation on implementing Good Distribution Practice (GDP) for pharmaceutical products in Hong Kong by adopting the PIC/S Guide to Good Distribution Practice. The proposal aims to strengthen supply chain integrity, align Hong Kong’s regulatory approach with internationally recognised standards and practices, and ensure that medicines are consistently stored, handled and transported under suitable conditions throughout distribution. The following draft documents were published on the website of the Drug Office of the Department of Health: Guide to Good Distribution Practice for Pharmaceutical Products (“GDP Guide”) Guidance for Industry: Guide to Good Distribution Practice for Pharmaceutical Products (“Guidance for Industry”) Revised Code of Practice for Holder of Wholesale Dealer Licence (“WDL COP”)According to the consultation documents, GDP would be introduced via additional application requirements and/or licensing conditions for licensed manufacturers and wholesale dealers. Implementation is planned to start with new applicants in Q3 2026 and extend to relevant existing licensees in Q3 2028. The consultation period runs from 1 April to 31 May 2026. Please also see the Consultation Document for further information.
来源:ECA GMP News · gmp-compliance.org